scispace - formally typeset
V

Victor E. Gould

Researcher at Rush Medical College

Publications -  175
Citations -  9093

Victor E. Gould is an academic researcher from Rush Medical College. The author has contributed to research in topics: Neuroendocrine differentiation & Immunohistochemistry. The author has an hindex of 54, co-authored 175 publications receiving 8932 citations. Previous affiliations of Victor E. Gould include Swedish University of Agricultural Sciences & Rush University.

Papers
More filters
Journal ArticleDOI

Synaptophysin: a marker protein for neuroendocrine cells and neoplasms

TL;DR: The results show that synaptophysin, and the vesicles that contain it, can occur in normal and neoplastic neuroendocrine cells of neural type, as demonstrated by colocalization with neurofilaments, as well as in those of epithelial type, including cytokeratin filaments and desmoplakins.
Journal Article

Neuroendocrine components of the bronchopulmonary tract: hyperplasias, dysplasias, and neoplasms.

TL;DR: The dispersed neuroendocrine system is represented in the bronchopulmonary tract by the solitary NE cells and the neuroepithelial bodies (NEBs), and when NEB cells from diethylnitrosamine-treated hamsters are cultured in vitro a notable proportion of the resulting endocrine cells express ACTH immunoreactivity.
Journal ArticleDOI

Lack of CD 29 (β1 integrin) and CD 54 (ICAM-1) adhesion molecules in intravascular lymphomatosis

TL;DR: One of the cases appears to be the first report of IL associated with a low-grade MALT lymphoma, and it is concluded that CD29 is currently regarded as critical for lymphocyte trafficking in general and for transvascular migration in particular, and CD54 is also involved in transv vascular lymphocyte migration, may contribute to its intravascular and disseminated distribution pattern.
Journal Article

Synaptophysin expression in neuroendocrine neoplasms as determined by immunocytochemistry.

TL;DR: It is concluded that synaptophysin is a significant as well as novel NE marker, and the use of antibody SY 38 as a broad range marker for the study and diagnosis of NE neoplasms is proposed.